However, inhibitors of the IL‐4 cascade such as, for example, the STAT6 inhibitor AS1517499 are in an early pre‐clinical development for immunological disorders.46 Furthermore, more work is necessary to fully understand the role of IL‐4/STAT6 in regulation of CSC‐like cells and confirm this signaling axis as a target for cancer therapy. Here, STAT6 is linked to cancer.